Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

MYOMYOMO, INC.

NYSE · CIK 0001369290
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
FY end1231
XBRL facts398

Identity from submissions API

NameMYOMO, INC.
CIK0001369290
TickersMYO
ExchangesNYSE
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-996-9058
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • MYOMO INC (2006-06-30T04:00:00.000Z → 2020-02-24T05:00:00.000Z)
Business address
137 PORTLAND STREET
4TH FLOOR
BOSTON
MA
02114
MA
Mailing address
137 PORTLAND STREET
4TH FLOOR
BOSTON
MA
02114
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

696 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001622627-26-000028 005-90202 261548294 34 16626
2026-11-09 10-Q 10-Q 0001193125-26-453623 001-38109 261536164 34 10491199 1 1
2026-11-09 8-K 8-K 2.02,9.01 0001193125-26-453593 001-38109 261536013 34 781510 1 1
2026-10-15 4 4 0001193125-26-422937 4936
2026-10-15 4/A 4/A 0001193125-26-422930 5252
2026-10-15 4 4 0001193125-26-422923 4786
2026-10-15 4 4 0001193125-26-422913 4904
2026-10-13 4 4 0001193125-26-420694 6648
2026-10-13 4 4 0001193125-26-420689 5095
2026-10-13 144 xsl144X01/primary_doc.xml 0001193125-26-419828 001-38109 261455177 33 5141
2026-10-13 4 4 0001193125-26-419757 5275
2026-10-13 3 3 0001193125-26-419754 15259
2026-10-13 S-8 S-8 0001193125-26-419752 333-299414 261454806 33 415406 1 1
2026-09-14 4 4 0001193125-26-390646 4964
2026-09-11 144 xsl144X01/primary_doc.xml 0001950047-26-009368 001-38109 261374826 33 6483
2026-09-04 4 4 0001193125-26-383718 4705
2026-09-02 144 xsl144X01/primary_doc.xml 0001000275-26-000103 001-38109 261354240 33 4820
2026-08-24 4/A 4/A 0001193125-26-361870 5312
2026-08-21 4 4 0001193125-26-361391 4980
2026-08-20 144 xsl144X01/primary_doc.xml 0001950047-26-008448 001-38109 261299889 33 7981
2026-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001622627-26-000016 005-90202 261265851 34 16613
2026-08-11 4 4 0001193125-26-343483 6521
2026-08-11 4 4 0001193125-26-343470 6523
2026-08-11 4 4 0001193125-26-343465 4900
2026-08-11 4 4 0001193125-26-343460 6370
2026-08-05 S-8 S-8 0001193125-26-335265 333-298015 261244123 33 294122 1 1
2026-08-05 10-Q 10-Q 0001193125-26-335149 001-38109 261243743 34 10035287 1 1
2026-08-05 8-K 8-K 2.02,9.01 0001193125-26-335109 001-38109 261243579 34 752845 1 1
2026-07-13 4 4 0001193125-26-302089 6682
2026-07-13 4 4 0001193125-26-302072 5100
2026-07-13 144 xsl144X01/primary_doc.xml 0001193125-26-302069 001-38109 261171620 33 5136
2026-06-29 8-K/A 8-K/A 5.02,5.03,5.07,9.01 0001193125-26-286969 001-38109 261131554 34 256410 1 1
2026-06-26 4 PRIMARY DOCUMENT 0001664091-26-000003 4976
2026-06-26 4 4 0001193125-26-285705 4955
2026-06-26 4 4 0001193125-26-285703 4949
2026-06-26 4 4 0001193125-26-285696 5211
2026-06-26 4 4 0001193125-26-285686 4971
2026-06-26 4 4 0001193125-26-285681 5181
2026-06-26 8-K 8-K 5.02,5.03,5.07,9.01 0001193125-26-285450 001-38109 261129019 34 239478 1 1
2026-06-12 4 4 0001193125-26-269675 4957
2026-06-12 4 4 0001193125-26-269642 4944
2026-06-12 4 4 0001193125-26-269607 4730
2026-06-12 144 xsl144X01/primary_doc.xml 0001193125-26-269486 001-38109 261086950 33 6583
2026-06-12 144 xsl144X01/primary_doc.xml 0001193125-26-269482 001-38109 261086930 33 5834
2026-06-09 4 4 0001193125-26-263916 4943
2026-06-09 4 4 0001193125-26-263886 4874
2026-06-09 4 4 0001193125-26-263742 4728
2026-06-09 4 4 0001193125-26-263732 5009
2026-06-08 4/A 4/A 0001193125-26-261825 5316
2026-06-08 144 xsl144X01/primary_doc.xml 0001193125-26-261754 001-38109 261072779 33 5968
2026-06-08 144 xsl144X01/primary_doc.xml 0001193125-26-261736 001-38109 261072721 33 5220
2026-06-01 4 4 0001193125-26-249844 4940
2026-05-28 4 4 0001193125-26-245953 6780
2026-05-28 144 xsl144X01/primary_doc.xml 0001950047-26-005246 001-38109 261037634 33 5579
2026-05-28 SD SD 0001193125-26-245307 001-38109 261036366 34 588967
2026-05-27 144 xsl144X01/primary_doc.xml 0001950047-26-005176 001-38109 261027946 33 9527
2026-05-18 4 4 0001193125-26-229323 6732
2026-05-18 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001161697-26-000118 005-90202 26995290 34 32358
2026-05-18 4 PRIMARY DOCUMENT 0001664091-26-000002 7556
2026-05-18 3 PRIMARY DOCUMENT 0001664091-26-000001 5002
2026-05-15 4 4 0001193125-26-227325 5126
2026-05-14 144 xsl144X01/primary_doc.xml 0001950047-26-004559 001-38109 26981164 33 7767
2026-05-14 ARS ARS 0001193125-26-224072 001-38109 26979128 34 816684
2026-05-14 DEFA14A DEFA14A 0001193125-26-224021 001-38109 26978941 34 319919
2026-05-14 DEF 14A DEF 14A 0001193125-26-223981 001-38109 26978749 34 5926807 1 1
2026-05-13 8-K 8-K 5.02,7.01,9.01 0001193125-26-221624 001-38109 26973335 34 190802 1 1
2026-05-07 10-Q 10-Q 0001193125-26-211988 001-38109 26953636 34 7999616 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-211928 001-38109 26953402 34 625843 1 1
2026-05-04 PRE 14A PRE 14A 0001193125-26-203959 001-38109 26937468 34 2933031 1 1
2026-04-29 10-K/A 10-K/A 0001193125-26-191496 001-38109 26915824 34 3108445 1 1
2026-04-16 4 4 0001193125-26-159101 4877
2026-04-16 3 3 0001193125-26-159079 14729
2026-04-16 8-K 8-K 5.02,7.01,9.01 0001193125-26-159060 001-38109 26867822 34 218056 1 1
2026-04-14 4/A 4/A 0001193125-26-155349 5309
2026-04-14 4 4 0001193125-26-155337 6680
2026-04-14 4 4 0001193125-26-155308 5096
2026-04-13 144 xsl144X01/primary_doc.xml 0001193125-26-152914 001-38109 26858026 33 4465
2026-03-17 4 4 0001193125-26-111290 4605
2026-03-16 4 4 0001193125-26-108732 4873
2026-03-12 4 4 0001193125-26-104456 15400
2026-03-09 S-8 S-8 0001193125-26-098742 333-294148 26735800 33 166402 1 1
2026-03-09 10-K 10-K 0001193125-26-098531 001-38109 26735158 34 13581473 1 1
2026-03-09 8-K 8-K 2.02,9.01 0001193125-26-098504 001-38109 26735029 34 749602 1 1
2026-02-11 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001622627-26-000003 005-90202 26619020 34 16528
2026-01-14 4 4 0001193125-26-012954 4960
2026-01-14 4 4 0001193125-26-012949 4844
2025-12-29 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001161697-25-000476 005-90202 251610703 34 59495
2025-12-16 8-K 8-K 5.02,9.01 0001193125-25-320896 001-38109 251575539 34 173101 1 1
2025-11-24 4 4 0001193125-25-293665 6254
2025-11-21 4 4 0001193125-25-291710 6678
2025-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001622627-25-000033 005-90202 251470590 34 16531
2025-11-10 10-Q 10-Q 0001193125-25-274278 001-38109 251466426 34 8544823 1 1
2025-11-10 8-K 8-K 1.01,2.02,2.03,3.02,9.01 0001193125-25-274238 001-38109 251466282 34 2201288 1 1
2025-11-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-021433 005-90202 251464612 34 9444
2025-09-11 4 4 0001015994-25-000004 4751
2025-08-26 4 4 0001258258-25-000004 4804
2025-08-19 4 4 0000950170-25-109938 4686
2025-08-18 4 4 0000950170-25-109565 4922
2025-08-11 8-K 8-K 2.02,9.01 0000950170-25-106562 001-38109 251202193 34 752673 1 1
2025-08-11 10-Q 10-Q 0000950170-25-106564 001-38109 251202188 34 8304350 1 1
2025-08-11 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001579206-25-000009 005-90202 251201687 34 16316
2025-07-02 4 4 0000950170-25-092544 4818
2025-07-02 4 4 0000950170-25-092541 4665
2025-06-30 144 xsl144X01/primary_doc.xml 0000950170-25-091826 001-38109 251093824 33 5134
2025-06-30 144 xsl144X01/primary_doc.xml 0000950170-25-091822 001-38109 251093812 33 5318
2025-06-18 8-K 8-K 7.01,9.01 0000950170-25-087709 001-38109 251055254 34 254197 1 1
2025-06-13 4 4 0000950170-25-086369 4809
2025-06-13 4 4 0000950170-25-086357 15051
2025-06-13 4 4 0000950170-25-086340 4658
2025-06-13 4 4 0000950170-25-086332 4774
2025-06-13 8-K 8-K 5.07 0000950170-25-086306 001-38109 251047315 34 159720 1 1
2025-06-12 4 4 0000950170-25-085735 4618
2025-06-12 4 4 0000950170-25-085731 14987
2025-06-12 4 4 0000950170-25-085725 14963
2025-06-12 4 4 0000950170-25-085722 14999
2025-06-06 4 4 0000950170-25-083376 15129
2025-06-06 4 4 0000950170-25-083362 14956
2025-06-06 144 xsl144X01/primary_doc.xml 0000950170-25-083351 001-38109 251032465 33 5979
2025-06-06 144 xsl144X01/primary_doc.xml 0000950170-25-083343 001-38109 251032430 33 5115
2025-05-23 SD SD 0000950170-25-076532 001-38109 25978684 34 640292
2025-05-15 4 4 0000950170-25-072803 16492
2025-05-15 4 4 0000950170-25-072776 15209
2025-05-14 4 4 0000950170-25-070945 4612
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001622627-25-000022 005-90202 25933993 34 16307
2025-05-07 10-Q 10-Q 0000950170-25-065682 001-38109 25921575 34 6833725 1 1
2025-05-07 8-K 8-K 2.02,9.01 0000950170-25-065657 001-38109 25921430 34 637174 1 1
2025-04-25 ARS ARS 0001193125-25-095120 001-38109 25870140 34 31328501
2025-04-25 DEFA14A DEFA14A 0000950170-25-058358 001-38109 25870130 34 1805110
2025-04-25 DEF 14A DEF 14A 0000950170-25-058354 001-38109 25870118 34 5929319 1 1
2025-04-10 8-K 8-K 4.01,5.02,7.01,9.01 0000950170-25-052686 001-38109 25826610 34 321310 1 1
2025-03-21 4/A 4/A 0000950170-25-043214 5195
2025-03-14 4 4 0000950170-25-039751 4491
2025-03-14 4/A 4/A 0000950170-25-039617 5156
2025-03-14 4 4 0000950170-25-039607 4959
2025-03-14 144 xsl144X01/primary_doc.xml 0001950047-25-001890 001-38109 25741393 33 10280
2025-03-14 4/A 4/A 0000950170-25-039582 6624
2025-03-13 4 4 0000950170-25-038823 8233
2025-03-13 4 4 0000950170-25-038813 4737
2025-03-13 4 4 0000950170-25-038812 6279
2025-03-13 4 4 0000950170-25-038808 6415
2025-03-13 144 xsl144X01/primary_doc.xml 0000950170-25-038805 001-38109 25736321 33 4605
2025-03-13 144 xsl144X01/primary_doc.xml 0000950170-25-038804 001-38109 25736287 33 4452
2025-03-13 144 xsl144X01/primary_doc.xml 0000950170-25-038787 001-38109 25736232 33 5312
2025-03-12 144 xsl144X01/primary_doc.xml 0001950047-25-001802 001-38109 25732489 33 6599
2025-03-10 S-8 S-8 0001193125-25-051013 333-285683 25724485 33 65414
2025-03-10 10-K 10-K 0000950170-25-036349 001-38109 25724132 34 11697517 1 1
2025-03-10 8-K 8-K 2.02,9.01 0000950170-25-036280 001-38109 25723772 34 782350 1 1
2025-02-20 8-K 8-K 1.01,2.04,9.01 0000950170-25-023403 001-38109 25641991 34 370779 1 1
2025-02-18 4 4 0000950170-25-022351 6754
2025-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-005545 005-90202 25603752 34 9674
2025-02-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001622627-25-000003 005-90202 25587706 34 16290
2025-01-24 4 4 0000950170-25-008883 7409
2025-01-24 4 4 0000950170-25-008877 7275
2025-01-24 4 4 0000950170-25-008872 7426
2025-01-24 4 4 0000950170-25-008859 7370
2025-01-22 4/A 4/A 0000950170-25-007772 5137
2024-12-05 8-K 8-K 1.01,8.01,9.01 0001193125-24-271571 001-38109 241529505 34 459716 1 1
2024-12-05 424B5 424B5 0001193125-24-271509 333-281311 241529125 33 477520
2024-12-04 424B5 424B5 0001193125-24-270678 333-281311 241526236 33 478944
2024-11-06 10-Q 10-Q 0000950170-24-122331 001-38109 241431153 34 7305300 1 1
2024-11-06 8-K 8-K 2.02,9.01 0000950170-24-122298 001-38109 241431005 34 634724 1 1
2024-11-05 4 4 0000950170-24-121547 4867
2024-11-04 144 xsl144X01/primary_doc.xml 0000950170-24-120594 001-38109 241423057 33 7970
2024-10-18 SC 13G/A rosalind_myo_13ga6_sep20.htm 0001622627-24-000049 005-90202 241380213 34 94218
2024-10-04 4 4 0000950170-24-112915 4847
2024-10-03 144 xsl144X01/primary_doc.xml 0000950170-24-112181 001-38109 241350632 33 7970
2024-09-09 4 4 0000950170-24-104735 4870
2024-09-05 4 4 0000950170-24-103753 6526
2024-09-04 144 xsl144X01/primary_doc.xml 0000950170-24-103561 001-38109 241278773 33 7302
2024-09-03 144 xsl144X01/primary_doc.xml 0000950170-24-102989 001-38109 241275315 33 7764
2024-08-28 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-08-28 16:01:00 9999999995-24-002664 333-281311 241258291 33 1870
2024-08-26 CORRESP filename1.htm 0001193125-24-207079 6872
2024-08-26 S-3/A S-3/A 0001193125-24-207074 333-281311 241241203 33 314070
2024-08-13 8-K 8-K 1.01,2.03,9.01 0000950170-24-096326 001-38109 241202129 34 1774966 1 1
2024-08-12 UPLOAD filename1.pdf 0000000000-24-009202 333-281311 40266
2024-08-07 4 4 0000950170-24-093230 4860
2024-08-06 S-8 S-8 0001193125-24-194988 333-281315 241180527 33 65518
2024-08-06 S-3 S-3 0001193125-24-194984 333-281311 241180504 33 380760
2024-08-06 10-Q 10-Q 0000950170-24-091839 001-38109 241179458 34 6769534 1 1
2024-08-06 8-K 8-K 2.02,9.01 0000950170-24-091801 001-38109 241179299 34 628542 1 1
2024-08-05 144 xsl144X01/primary_doc.xml 0000950170-24-090480 001-38109 241173731 33 7966
2024-07-15 8-K 8-K 1.01,2.03,9.01 0001193125-24-179060 001-38109 241117305 34 555881 1 1
2024-07-11 SC 13G/A rosalind_myo_13ga5_jul20.htm 0001622627-24-000041 005-90202 241113493 34 94211
2024-07-11 SC 13G/A rosalind_myo_13ga5_jul20.htm 0001622627-24-000044 005-90202 241112865 34 94211
2024-07-08 4 4 0000950170-24-082149 4856
2024-07-08 8-K 8-K 2.02,9.01 0000950170-24-081953 001-38109 241103424 34 220496 1 1
2024-07-03 144 xsl144X01/primary_doc.xml 0000950170-24-081665 001-38109 241101128 33 8635
2024-07-02 4/A 4/A 0000950170-24-081017 5423
2024-07-02 4/A 4/A 0000950170-24-081005 5440
2024-07-02 4 4 0000950170-24-080993 4790
2024-07-02 4 4 0000950170-24-080990 4803
2024-07-02 4 4 0000950170-24-080988 4637
2024-07-01 144 xsl144X01/primary_doc.xml 0000950170-24-079802 001-38109 241092167 33 5792
2024-07-01 144 xsl144X01/primary_doc.xml 0000950170-24-079797 001-38109 241092137 33 5951
2024-07-01 144 xsl144X01/primary_doc.xml 0000950170-24-079791 001-38109 241092054 33 7966
2024-06-12 4 4 0000950170-24-072455 4949
2024-06-12 4 4 0000950170-24-072450 5117
2024-06-12 4 4 0000950170-24-072449 5101
2024-06-10 144 xsl144X01/primary_doc.xml 0000950170-24-071432 001-38109 241033829 33 8005
2024-06-10 144 xsl144X01/primary_doc.xml 0000950170-24-071425 001-38109 241033782 33 5316
2024-06-10 144 xsl144X01/primary_doc.xml 0000950170-24-071414 001-38109 241033737 33 5160
2024-06-07 4 4 0000950170-24-070818 4727
2024-06-07 4 4 0000950170-24-070801 4880
2024-06-07 4 4 0000950170-24-070787 4896
2024-06-07 4 4 0000950170-24-070771 4844
2024-06-07 4 4 0000950170-24-070753 4704
2024-06-07 4 4 0000950170-24-070737 4832
2024-06-07 4 4 0000950170-24-070721 4826
2024-06-07 4 4 0000950170-24-070689 4826
2024-06-07 4 4 0000950170-24-070615 4799
2024-06-07 8-K 8-K 5.07 0001193125-24-157320 001-38109 241029321 34 150026 1 1
2024-06-05 4 4 0000950170-24-069474 4891
2024-06-04 SC 13G/A AMENDMENT NO. 2 0001214659-24-010536 005-90202 241017832 34 71428
2024-06-03 144 xsl144X01/primary_doc.xml 0000950170-24-067709 001-38109 241012321 33 7877
2024-05-31 4 4 0000950170-24-067480 4586
2024-05-30 SD SD 0000950170-24-066705 001-38109 241006134 34 460490
2024-05-17 4 4 0000950170-24-061827 4811
2024-05-15 144 xsl144X01/primary_doc.xml 0001950047-24-003770 001-38109 24952982 33 29516
2024-05-08 8-K 8-K 2.02,9.01 0000950170-24-055687 001-38109 24926271 34 508719 1 1
2024-05-08 10-Q 10-Q 0000950170-24-055660 001-38109 24926128 34 5687433 1 1
2024-05-06 4 4 0000950170-24-053682 4886
2024-05-06 8-K 8-K 8.01,9.01 0000950170-24-053228 001-38109 24916012 34 196940 1 1
2024-05-03 144 xsl144X01/primary_doc.xml 0000950170-24-052490 001-38109 24910852 33 7288
2024-04-26 ARS ARS 0001193125-24-115944 001-38109 24879024 34 12543525
2024-04-26 DEFA14A DEFA14A 0001193125-24-115935 001-38109 24879009 34 501221
2024-04-26 DEF 14A DEF 14A 0001193125-24-115929 001-38109 24878993 34 969859
2024-04-25 SC 13G/A rosalind_myo_13ga4_apr25.htm 0001622627-24-000024 005-90202 24878118 34 94265
2024-04-04 4 4 0000950170-24-041921 4890
2024-04-02 144 xsl144X01/primary_doc.xml 0000950170-24-040525 001-38109 24816323 33 7290
2024-03-28 3 3 0000950170-24-038142 15426
2024-03-28 8-K 8-K 5.02,7.01,9.01 0000950170-24-038054 001-38109 24799130 34 205694 1 1
2024-03-18 4 4 0000950170-24-032523 4585
2024-03-13 4 4 0000950170-24-030822 4684
2024-03-13 4 4 0000950170-24-030821 4853
2024-03-13 4 4 0000950170-24-030820 4837
2024-03-11 144 xsl144X01/primary_doc.xml 0000950170-24-028923 001-38109 24736590 33 6621
2024-03-11 144 xsl144X01/primary_doc.xml 0000950170-24-028917 001-38109 24736566 33 4469
2024-03-11 144 xsl144X01/primary_doc.xml 0000950170-24-028916 001-38109 24736564 33 4608
2024-03-08 10-K 10-K 0000950170-24-028326 001-38109 24732166 34 9459679 1 1
2024-03-07 8-K 8-K 2.02,9.01 0000950170-24-027949 001-38109 24730169 34 626687 1 1
2024-03-06 4 4 0000950170-24-026872 4878
2024-03-04 144 xsl144X01/primary_doc.xml 0000950170-24-025160 001-38109 24717485 33 6500
2024-03-01 8-K 8-K 8.01,9.01 0000950170-24-023543 001-38109 24707053 34 178553 1 1
2024-02-22 8-K 8-K 5.02,9.01 0000950170-24-018877 001-38109 24665770 34 315996 1 1
2024-02-14 SC 13G/A rosalind_myo_13ga3_feb20.htm 0001622627-24-000010 005-90202 24642664 34 94301
2024-02-14 SC 13G/A rosalind_myo_13ga3_feb20.htm 0001622627-24-000012 005-90202 24641828 34 94301
2024-02-14 SC 13G/A formsc13ga.htm 0001493152-24-006675 005-90202 24638385 34 171131
2024-02-07 SC 13G/A formsc13ga.htm 0001493152-24-005333 005-90202 24606305 34 93810
2024-02-05 4 4 0000950170-24-011407 4884
2024-02-02 144 xsl144X01/primary_doc.xml 0000950170-24-010611 001-38109 24592695 33 7034
2024-01-22 4 4 0000950170-24-006122 4701
2024-01-17 8-K 8-K 1.01,2.02,8.01,9.01 0001193125-24-009264 001-38109 24538658 34 618328 1 1
2024-01-17 424B5 424B5 0001193125-24-009254 333-256159 24538510 33 558257
2024-01-12 4/A 4/A 0000950170-24-004313 4945
2024-01-12 4/A 4/A 0000950170-24-004311 5114
2024-01-04 4 4 0000950170-24-002078 4894
2024-01-02 144 xsl144X01/primary_doc.xml 0000950170-24-000391 001-38109 24503719 33 7034
2023-12-19 8-K 8-K 5.02 0000950170-23-071510 001-38109 231497750 34 154647 1 1
2023-12-14 4 4 0000950170-23-070531 4388
2023-12-08 4 4 0000950170-23-069146 4784
2023-12-08 144 xsl144X01/primary_doc.xml 0001950047-23-005826 001-38109 231475999 33 5458
2023-12-05 4 4 0000950170-23-068302 6393
2023-12-04 144 xsl144X01/primary_doc.xml 0000950170-23-067874 001-38109 231464745 33 6237
2023-12-04 144 xsl144X01/primary_doc.xml 0000950170-23-067487 001-38109 231461468 33 6200
2023-11-30 4 4 0000950170-23-067098 4766
2023-11-28 144 xsl144X01/primary_doc.xml 0001950047-23-005433 001-38109 231447271 33 4711
2023-11-07 10-Q 10-Q 0000950170-23-060417 001-38109 231385227 34 7766437 1 1
2023-11-07 8-K 8-K 2.02,9.01 0000950170-23-060269 001-38109 231384100 34 786786 1 1
2023-11-06 4 4 0000950170-23-059604 4654
2023-11-06 8-K 8-K 8.01,9.01 0000950170-23-059039 001-38109 231378341 34 205059 1 1
2023-11-03 144 xsl144X01/primary_doc.xml 0000950170-23-058867 001-38109 231376883 33 6326
2023-11-02 8-K 8-K 8.01,9.01 0000950170-23-058168 001-38109 231372174 34 205595 1 1
2023-10-03 4 4 0000950170-23-051684 4654
2023-10-02 144 xsl144X01/primary_doc.xml 0000950170-23-051211 001-38109 231301042 33 6325
2023-09-11 4 4 0000950170-23-047520 4678
2023-09-07 SC 13G/A formsc13ga.htm 0001493152-23-031898 005-90202 231240872 34 92336
2023-09-06 4 4 0000950170-23-046821 4795
2023-09-05 144 xsl144X01/primary_doc.xml 0000950170-23-046526 001-38109 231237476 33 7734
2023-08-31 4 4 0000950170-23-045865 4694
2023-08-31 SC 13G/A AMENDMENT NO. 1 0001214659-23-011902 005-90202 231228960 34 73499
2023-08-30 4 4 0000950170-23-045501 4633
2023-08-30 4 4 0000950170-23-045473 4460
2023-08-30 4 4 0000950170-23-045447 6372
2023-08-28 8-K 8-K 1.01,9.01 0001193125-23-222703 001-38109 231217261 34 326653 1 1
2023-08-28 424B5 424B5 0001193125-23-222697 333-256159 231217180 33 576736
2023-08-28 SC 13G/A MYOMO, INC. 13G/A 0001622627-23-000031 005-90202 231213908 34 94894
2023-08-24 424B5 424B5 0001193125-23-220164 333-256159 231202586 33 581435
2023-08-24 424B5 424B5 0001193125-23-220138 333-256159 231202475 33 99755
2023-08-24 8-K 8-K 1.02,8.01,9.01 0000950170-23-044373 001-38109 231202211 34 220608 1 1
2023-08-09 10-Q 10-Q 0000950170-23-040625 001-38109 231155436 34 8569091 1 1
2023-08-09 8-K 8-K 2.02,9.01 0000950170-23-040584 001-38109 231155259 34 892840 1 1
2023-08-03 4 4 0000950170-23-038163 4789
2023-08-02 144 xsl144X01/primary_doc.xml 0000950170-23-037331 001-38109 231137107 33 7732
2023-07-05 4 FORM 4 SUBMISSION 0001209191-23-041159 8872
2023-07-03 144 xsl144X01/primary_doc.xml 0000950170-23-031410 001-38109 231065578 33 7730
2023-06-30 4 FORM 4 SUBMISSION 0001209191-23-040343 4999
2023-06-30 4 FORM 4 SUBMISSION 0001209191-23-040341 8877
2023-06-30 4 FORM 4 SUBMISSION 0001209191-23-040334 4866
2023-06-30 4 FORM 4 SUBMISSION 0001209191-23-040330 4964
2023-06-30 4 FORM 4 SUBMISSION 0001209191-23-040324 8825
2023-06-30 4 FORM 4 SUBMISSION 0001209191-23-040323 4919
2023-06-30 4 FORM 4 SUBMISSION 0001209191-23-040320 4823
2023-06-30 4 FORM 4 SUBMISSION 0001209191-23-040318 4947
2023-06-30 4 FORM 4 SUBMISSION 0001209191-23-040313 11589
2023-06-28 S-8 S-8 0001193125-23-177496 333-272982 231052160 33 67714
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036463 10288
2023-06-12 144 xsl144X01/primary_doc.xml 0000950170-23-027372 001-38109 231007224 33 6973
2023-06-09 8-K 8-K 5.07 0000950170-23-027137 001-38109 231003948 34 209056 1 1
2023-06-09 144 xsl144X01/primary_doc.xml 0000950170-23-027127 001-38109 231003849 33 6393
2023-06-06 4 FORM 4 SUBMISSION 0001209191-23-034753 8804
2023-06-05 144 xsl144X01/primary_doc.xml 0000950170-23-026366 001-38109 23992678 33 6387
2023-05-10 10-Q 10-Q 0000950170-23-020576 001-38109 23906839 34 6686360 1 1
2023-05-10 8-K 8-K 2.02,9.01 0000950170-23-020555 001-38109 23906652 34 725338 1 1
2023-05-03 4 FORM 4 SUBMISSION 0001209191-23-027066 8802
2023-05-03 144 xsl144X01/primary_doc.xml 0000950170-23-016956 001-38109 23882356 33 6387
2023-04-28 ARS ARS 0001193125-23-124523 001-38109 23860547 34 13765935
2023-04-28 DEFA14A DEFA14A 0001193125-23-124519 001-38109 23860533 34 1159422
2023-04-28 DEF 14A DEF 14A 0001193125-23-124512 001-38109 23860522 34 1549242
2023-04-10 8-K 8-K 8.01,9.01 0000950170-23-012238 001-38109 23809772 34 216180 1 1
2023-04-03 4 FORM 4 SUBMISSION 0001209191-23-022342 8722
2023-03-28 SC 13G Myomo.doc.txt 0001971160-23-000003 005-90202 23767636 34 7529
2023-03-13 10-K 10-K 0000950170-23-007560 001-38109 23727186 34 11591638 1 1
2023-03-13 8-K 8-K 2.02,9.01 0000950170-23-007459 001-38109 23725845 34 907539 1 1
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-017971 4847
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-017968 8725
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-017965 4714
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-017962 4812
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016286 8690
2023-02-24 3 FORM 3 SUBMISSION 0001209191-23-012920 8313
2023-02-15 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-23-011956 005-90202 23634593 34 49470
2023-02-07 SC 13G/A SCHEDULE 13G AMENDMENT NO. 2 0001193125-23-026167 005-90202 23592712 34 82214
2023-02-03 4 FORM 4 SUBMISSION 0001209191-23-007024 8696
2023-01-30 8-K 8-K 5.02,9.01 0000950170-23-001376 001-38109 23567926 34 230617 1 1
2023-01-20 SC 13G formsc13g.htm 0001493152-23-002010 005-90202 23540784 34 171380
2023-01-19 SC 13G formsc13g.htm 0001493152-23-001832 005-90202 23536139 34 93348
2023-01-18 4 FORM 4 SUBMISSION 0001209191-23-003862 4802
2023-01-18 4 FORM 4 SUBMISSION 0001209191-23-003850 4669
2023-01-18 4 FORM 4 SUBMISSION 0001209191-23-003848 4768
2023-01-17 SC 13G SCHEDULE 13G 0001213900-23-003011 005-90202 23531398 34 52223
2023-01-13 8-K 8-K 1.01,9.01 0000950170-23-000773 001-38109 23529638 34 1093052 1 1
2023-01-13 424B4 424B4 0001193125-23-008486 333-268705 23529552 33 635733
2023-01-11 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-01-11 17:00:00 9999999995-23-000110 333-268705 23530039 33 1797
2023-01-11 S-1MEF S-1MEF 0001193125-23-006589 333-269189 23524364 33 63701
2023-01-11 S-1/A S-1/A 0001193125-23-005775 333-268705 23522236 33 716895
2023-01-10 8-K 8-K 8.01,9.01 0000950170-23-000624 001-38109 23521571 34 242369 1 1
2023-01-10 S-1/A S-1/A 0001193125-23-005448 333-268705 23520660 33 1001489
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-001387 8694
2023-01-04 S-1/A S-1/A 0001193125-23-001339 333-268705 23505041 33 1054902
2022-12-07 S-1 S-1 0001193125-22-300231 333-268705 221450880 33 611695
2022-12-07 8-K 8-K 8.01 0000950170-22-026154 001-38109 221450383 34 168583 1 1
2022-12-05 4 FORM 4 SUBMISSION 0001209191-22-059803 8697
2022-12-05 4 FORM 4 SUBMISSION 0001209191-22-059765 7186
2022-11-25 SC 13G/A form13ga.htm 0001493152-22-033662 005-90202 221417938 34 89110
2022-11-23 4 FORM 4 SUBMISSION 0001209191-22-058709 7333
2022-11-22 4 FORM 4 SUBMISSION 0001209191-22-058524 4688
2022-11-10 10-Q 10-Q 0000950170-22-024522 001-38109 221377722 34 7760352 1 1
2022-11-10 8-K 8-K 2.02,9.01 0000950170-22-024507 001-38109 221377610 34 905685 1 1
2022-11-04 4 FORM 4 SUBMISSION 0001209191-22-055833 8697
2022-10-28 DEF 14A DEF 14A 0001193125-22-271818 001-38109 221339077 34 798400
2022-10-18 PRE 14A PRE 14A 0001193125-22-264497 001-38109 221316467 34 798884
2022-10-03 4 FORM 4 SUBMISSION 0001209191-22-051849 8695
2022-09-27 8-K 8-K 8.01 0000950170-22-018906 001-38109 221271879 34 170905 1 1
2022-09-06 4 FORM 4 SUBMISSION 0001209191-22-048761 8699
2022-08-08 4 FORM 4 SUBMISSION 0001209191-22-044837 4720
2022-08-04 4 FORM 4 SUBMISSION 0001209191-22-044423 8695
2022-08-03 10-Q 10-Q 0000950170-22-014267 001-38109 221132875 34 7184983 1 1
2022-08-03 8-K 8-K 2.02,9.01 0000950170-22-014246 001-38109 221132675 34 872198 1 1
2022-08-02 8-K 8-K 1.01,9.01 0001193125-22-210150 001-38109 221129887 34 683319 1 1
2022-08-02 424B5 424B5 0001193125-22-210144 333-256159 221129870 33 470235
2022-08-02 424B5 424B5 0001193125-22-210141 333-256159 221129855 33 355568
2022-07-07 8-K 8-K 8.01,9.01 0000950170-22-012519 001-38109 221071821 34 218734 1 1
2022-07-05 4 FORM 4 SUBMISSION 0001209191-22-040760 8689
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037262 8690
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037261 4864
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037260 4998
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-035965 4965
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-035945 8843
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-035932 4831
2022-06-10 8-K 8-K 5.07 0001193125-22-171934 001-38109 221008879 34 151763 1 1
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035673 4930
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034354 8688
2022-05-24 4 FORM 4 SUBMISSION 0001209191-22-031714 4928
2022-05-24 4 FORM 4 SUBMISSION 0001209191-22-031711 10540
2022-05-24 4 FORM 4 SUBMISSION 0001209191-22-031703 6528
2022-05-24 4 FORM 4 SUBMISSION 0001209191-22-031640 4893
2022-05-18 SC 13G/A SCHEDULE 13G AMENDMENT NO. 1 0001193125-22-153498 005-90202 22936984 34 86274
2022-05-11 10-Q 10-Q 0001564590-22-019527 001-38109 22913935 34 5793891 1 1
2022-05-11 8-K 8-K 2.02,9.01 0001193125-22-147509 001-38109 22913803 34 283611 1 1
2022-05-03 4 FORM 4 SUBMISSION 0001209191-22-026720 8686
2022-04-29 DEFA14A DEFA14A 0001193125-22-130696 001-38109 22870485 34 312746
2022-04-29 DEF 14A DEF 14A 0001193125-22-130675 001-38109 22870476 34 460892
2022-04-04 4 FORM 4 SUBMISSION 0001209191-22-022670 8690
2022-04-04 8-K 8-K 8.01,9.01 0001193125-22-095127 001-38109 22802737 34 171625 1 1
2022-03-16 4 FORM 4 SUBMISSION 0001209191-22-019070 4887
2022-03-11 4 FORM 4 SUBMISSION 0001209191-22-018311 4889
2022-03-11 10-K 10-K 0001564590-22-009827 001-38109 22732732 34 11383264 1 1
2022-03-09 8-K 8-K 2.02,9.01 0001193125-22-070573 001-38109 22725497 34 310948 1 1
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017332 8690
2022-02-11 SC 13G/A formsc13ga.htm 0001493152-22-003951 005-90202 22619994 34 91950
2022-02-04 4 FORM 4 SUBMISSION 0001209191-22-007308 8696

Latest XBRL company facts

One latest value per concept from companyfacts (398 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 40.10M 2026-11-03 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
dei EntityPublicFloat Entity Public Float USD 62.36M 2025-06-30 2025 FY 10-K/A 2026-04-29 0001193125-26-191496
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD -35,409 2025-01-01 2025-12-31 DEF 14A 2026-05-14 0001193125-26-223981
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 649,020 2025-01-01 2025-12-31 DEF 14A 2026-05-14 0001193125-26-223981
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD -348,553 2025-01-01 2025-12-31 DEF 14A 2026-05-14 0001193125-26-223981
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.20M 2025-01-01 2025-12-31 DEF 14A 2026-05-14 0001193125-26-223981
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 178.08 2025-01-01 2025-12-31 DEF 14A 2026-05-14 0001193125-26-223981
ffd NetFeeAmt NetFeeAmt USD 75.93 2026-10-09 S-8 2026-10-13 0001193125-26-419752
ffd TtlFeeAmt TtlFeeAmt USD 75.93 2026-10-09 S-8 2026-10-13 0001193125-26-419752
ffd TtlOfferingAmt TtlOfferingAmt USD 872,812 2026-10-09 S-8 2026-10-13 0001193125-26-419752
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-09 S-8 2026-10-13 0001193125-26-419752
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 6.86M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 6.86M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap AccountsPayableRelatedPartiesCurrentAndNoncurrent Accounts Payable, Related Parties USD 29,600 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009827
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 1.11M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 5.92M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap AccountsReceivableRelatedParties Accounts Receivable, Related Parties USD 44,900 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009827
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 86,917 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 2.92M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap AccruedInsuranceCurrent Accrued Insurance, Current USD 235,640 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 149,580 2016-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079222
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 130,937 2016-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079222
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 113,423 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-056254
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 23,750 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042928
us-gaap AccruedRoyaltiesCurrentAndNoncurrent Accrued Royalties USD 90,710 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060417
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.85M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 189,459 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 51.40M 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020451
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 132.52M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap AdjustmentsToAdditionalPaidInCapitalMarkToMarket Adjustments to Additional Paid in Capital, Fair Value USD 5.17M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 156,725 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap AdvertisingExpense Advertising Expense USD 6.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 2.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables Allowance for Doubtful Accounts, Premiums and Other Receivables USD 26,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024522
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 102,700 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 17,765 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 215,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 161,869 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009827
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 3.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap Assets Assets USD 33.80M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap AssetsCurrent Assets, Current USD 23.50M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap CapitalizedComputerSoftwareAdditions Capitalized Computer Software, Additions USD 241,200 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap CapitalizedComputerSoftwareNet Capitalized Computer Software, Net USD 1.37M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap CapitalUnitsAuthorized Capital Units, Authorized shares 110.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap Cash Cash USD 10.20M 2022-06-30 2022 Q2 10-Q 2022-08-03 0000950170-22-014267
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 11.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 8.36M 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-211988
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 12.16M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079222
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 11.95M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 9.17M 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-027998
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 11.67M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 1.16M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001193125-18-159201
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -3.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments USD -888 2020-07-01 2020-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-056254
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 3.76M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 5.13M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 1.10M 2023-06-09 2023 Q2 10-Q 2023-08-09 0000950170-23-040625
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0 2024-01-19 2025 Q3 10-Q 2025-11-10 0001193125-25-274278
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 100.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 40.05M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 40.05M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap CommonStockValue Common Stock, Value, Issued USD 4,005 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -11.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 27,340 2020-03-31 2020 Q1 10-Q 2020-05-14 0001564590-20-025466
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028326
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 50,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028326
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 2.20M 2016-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079222
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 78,045 2020-09-30 2020 Q3 10-Q 2020-11-10 0001564590-20-052980
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 92,100 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap CostOfReimbursableExpense Cost of Reimbursable Expense (Deprecated 2018-01-31) USD 7,800 2017-01-01 2017-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020451
us-gaap CostOfRevenue Cost of Revenue USD 10.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap CostOfServices Cost of Services (Deprecated 2018-01-31) USD 231,800 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020451
us-gaap CumulativeEffectOnRetainedEarningsNetOfTax1 Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) USD -123,447 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-14 0001564590-20-025466
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 504,532 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 504,532 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap CustomerAdvancesCurrent Customer Advances, Current USD 106,609 2018-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap DebtAndEquitySecuritiesRealizedGainLoss Debt and Equity Securities, Realized Gain (Loss) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0000950170-25-036349
us-gaap DebtDefaultLongtermDebtAmount Debt Instrument, Debt Default, Amount USD 4.00M 2024-07-11 2025 Q3 10-Q 2025-11-10 0001193125-25-274278
us-gaap DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate pure 0.224 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 12.65M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal USD 24,300 2025-06-01 2025-08-31 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 2.29M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap DebtInstrumentUnamortizedDiscountCurrent Debt Instrument, Unamortized Discount, Current USD 295,486 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap DebtInstrumentUnamortizedDiscountNoncurrent Debt Instrument, Unamortized Discount, Noncurrent USD 1.99M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap DeferredIncome Deferred Income USD 1,500 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-056254
us-gaap DeferredIncomeCurrent Deferred Income, Current USD 139,094 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.68M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 108,402 2019-06-30 2019 Q2 10-Q 2019-08-08 0001564590-19-030866
us-gaap DeferredRevenue Deferred Revenue USD 139,100 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 570 2019-06-30 2019 Q2 10-Q 2019-08-08 0001564590-19-030866
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 0 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028326
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 48,900 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 23.24M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.68M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 16.80M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 2.72M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 1.42M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 926,798 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 21.56M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap Depreciation Depreciation USD 859,354 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 1.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap DepreciationExpenseOnReclassifiedAssets Depreciation Expense on Reclassified Assets USD 859,400 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap DerivativeAssetsLiabilitiesAtFairValueNet Derivative Assets (Liabilities), at Fair Value, Net USD 558,200 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-211988
us-gaap DerivativeLiabilities Derivative Liability USD 3.08M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 1.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 311,733 2017-06-30 2017 Q2 10-Q 2017-08-14 0001213900-17-008679
us-gaap DerivativeLiabilityFairValueOfCollateral Derivative Liability, Fair Value of Collateral USD 1.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 0 2018-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.26 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.41 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-11 0001564590-22-019527
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.26 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.033 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.436 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.15 2022-08-16 2022 FY 10-K 2023-03-13 0000950170-23-007560
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.016 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.1 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingenciesDomestic Effective Income Tax Rate Reconciliation, Tax Contingency, Domestic, Percent pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic Effective Income Tax Rate Reconciliation, Tax Settlement, Domestic, Percent pure 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Percent pure 0.019 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -61,719 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 319,447 2017-06-30 2017 Q2 10-Q 2017-08-14 0001213900-17-008679
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap EquityMethodInvestmentOtherThanTemporaryImpairment Equity Method Investment, Other than Temporary Impairment USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060417
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 772,700 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020451
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.609 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020451
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.027 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020451
us-gaap FairValueInputsDiscountRate Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) pure 0.25 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079222
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases USD 372,827 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-10 0001564590-21-012068
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 13,267 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 197,370 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 30,715 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 166,655 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 232,171 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 73,317 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 48,878 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 48,878 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 48,878 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 12,220 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 34,801 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 548,059 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.088 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap ForeignIncomeTaxExpenseBenefitContinuingOperations Foreign Income Tax Expense (Benefit), Continuing Operations USD 504,532 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD 122,706 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009827
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-13 0000950170-23-007560
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -99,840 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060417
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 839,064 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-211988
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 10.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap GrossProfit Gross Profit USD 24.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -16.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -10.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 1.63M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap IncomeTaxesPaid Income Taxes Paid USD 129,390 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 330,939 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 321,993 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -3.16M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 1.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 1.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD 94,554 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD -377,503 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -106,569 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-10 0001564590-21-012068
us-gaap IncreaseDecreaseInDeferredCharges Increase (Decrease) in Deferred Charges USD 431,961 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079222
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -79,128 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -7,279 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD -191,120 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042928
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD -22,492 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-14 0001564590-19-019136
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-13 0000950170-23-007560
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -248,464 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-10 0001564590-21-012068
us-gaap InterestExpenseDebt Interest Expense, Debt USD 218,803 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009827
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 59,536 2017-01-01 2017-03-31 2018 Q1 10-Q 2018-05-10 0001193125-18-159201
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 1.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 444,663 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap InventoryNet Inventory, Net USD 3.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap InventoryRawMaterialsAndSupplies Inventory, Raw Materials and Supplies, Gross USD 2.62M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 24,000 2018-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010809
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 31,119 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap InventoryWorkInProcessAndRawMaterials Inventory, Work in Process and Raw Materials USD 1.80M 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028326
us-gaap InventoryWriteDown Inventory Write-down USD -71,265 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-10 0001564590-21-012068
us-gaap InvestmentCompanyCommittedCapital Investment Company, Committed Capital USD 12.50M 2025-11-04 2026 Q1 10-Q 2026-05-07 0001193125-26-211988
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 9.00M 2016-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079222
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures USD 0 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028326
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 31,845 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap LeaseCost Lease, Cost USD 1.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 9.96M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 4.87M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.53M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 59,459 2020-12-31 2020 FY 10-K 2021-03-10 0001564590-21-012068
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.65M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.65M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.59M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 322,501 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2.20M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap Liabilities Liabilities USD 31.05M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 33.80M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap LiabilitiesCurrent Liabilities, Current USD 12.27M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 1,495 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042928
us-gaap LineOfCredit Long-term Line of Credit USD 375,000 2024-08-31 2026 Q1 10-Q 2026-05-07 0001193125-26-211988
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 900,000 2024-07-11 2024 Q3 10-Q 2024-11-06 0000950170-24-122331
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 1.00M 2025-09-30 2025 Q3 10-Q 2025-11-10 0001193125-25-274278
us-gaap LongTermDebt Long-term Debt USD 11.65M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 1.79M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 888,961 2019-12-31 2020 FY 10-K 2021-03-10 0001564590-21-012068
us-gaap LossContingencyAccrualCarryingValueCurrent Loss Contingency, Accrual, Current USD 55,000 2023-12-31 2024 FY 10-K 2025-03-10 0000950170-25-036349
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -370,656 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 2.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -5.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -11.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -11.51M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-10 0001564590-21-012068
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -10.72M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-13 0000950170-23-007560
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 876,458 2016-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079222
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 876,458 2017-09-30 2017 Q3 10-Q 2017-11-08 0001213900-17-011587
us-gaap OperatingExpenses Operating Expenses USD 31.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -7.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 691,200 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 7.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 804,311 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 6.96M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 6.33M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 542,600 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010809
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.085 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 1.70M 2018-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 399,314 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 15,997 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 23,270 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 24,942 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD 89,319 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross USD 135,635 2018-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010809
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 118,060 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009827
us-gaap OtherLongTermDebt Other Long-term Debt USD 77,892 2020-06-30 2020 Q2 10-Q 2020-08-10 0001564590-20-038994
us-gaap OtherNoncashExpense Other Noncash Expense USD 12,606 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001564590-19-030866
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 61,004 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -3.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0000950170-25-036349
us-gaap OtherShortTermInvestments Other Short-term Investments USD 4.30M 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-211988
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 1.01M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001213900-17-008679
us-gaap PaymentsForRepurchaseOfPrivatePlacement Payments for Repurchase of Private Placement USD 2,500 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001213900-17-008679
us-gaap PaymentsForTenantImprovements Payments for Tenant Improvements USD 516,300 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0000950170-25-036349
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 255,533 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009827
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 857,621 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 144,582 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 370,500 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028326
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 411,007 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap PaymentsToDevelopSoftware Payments to Develop Software USD 241,165 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap PreferredStockAccretionOfRedemptionDiscount Preferred Stock, Accretion of Redemption Discount USD -274,011 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-08 0001213900-17-011587
us-gaap PreferredStockNoParValue Preferred Stock, No Par Value USD/shares 0 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap PreferredStockRedemptionPremium Preferred Stock Redemption Premium USD 274,011 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 2.53M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 1.77M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 13.50M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009827
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 1.10M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009827
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet Proceeds from Issuance of Long-term Debt and Capital Securities, Net USD 12.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 2.92M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 4.80M 2021-10-31 2021 FY 10-K 2022-03-11 0001564590-22-009827
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 7.92M 2017-06-09 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 3.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 3 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009827
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001193125-25-274278
us-gaap ProductWarrantyAccrual Standard and Extended Product Warranty Accrual USD 148,296 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ProductWarrantyAccrualClassifiedCurrent Product Warranty Accrual, Current USD 155,806 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap ProductWarrantyAccrualPayments Standard and Extended Product Warranty Accrual, Decrease for Payments USD 180,156 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ProductWarrantyAccrualPreexistingIncreaseDecrease Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ProductWarrantyAccrualWarrantiesIssued Standard and Extended Product Warranty Accrual, Increase for Warranties Issued USD 198,837 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ProductWarrantyExpense Product Warranty Expense USD 56,900 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-027998
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -11.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap ProgramRightsObligations Program Rights Obligations USD 519,476 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 4.07M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.73M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap PropertyPlantAndEquipmentTransfersAndChanges Property, Plant and Equipment, Transfers and Changes USD 2,514 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009827
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD 0 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-09 0000950170-23-040625
us-gaap RepaymentsOfDebt Repayments of Debt USD 4.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 1.22M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 5.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap RestrictedCash Restricted Cash USD 575,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 11.67M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 75,000 2019-12-31 2020 FY 10-K 2021-03-10 0001564590-21-012068
us-gaap RestrictedCashEquivalents Restricted Cash Equivalents USD 11.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings Restricted Stock, Shares Issued Net of Shares for Tax Withholdings shares 489 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009827
us-gaap RestrictedStockValueSharesIssuedNetOfTaxWithholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings USD 370,656 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap RestructuringReserveTranslationAdjustment Restructuring Reserve, Foreign Currency Translation Gain (Loss) USD 19,900 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -129.95M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 34.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 25,900 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-13 0000950170-23-007560
us-gaap Revenues Revenues USD 1.00B 2022-08-16 2022 FY 10-K 2023-03-13 0000950170-23-007560
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 197,370 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 15.80M 2024-12-06 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 3.45M 2024-12-06 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 5 2024-12-06 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 522,914 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001213900-17-008679
us-gaap SecuritiesSoldUnderAgreementsToRepurchase Securities Sold under Agreements to Repurchase USD 5.00M 2023-01-31 2023 Q2 10-Q 2023-08-09 0000950170-23-040625
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 15.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 18.78M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028326
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 2.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 668,250 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 1.37M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 980,173 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0000950170-24-122331
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 314,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-08 0001213900-17-011587
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.621 2018-01-01 2018-03-31 2019 Q1 10-Q 2019-05-14 0001564590-19-019136
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.614 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-14 0001564590-20-025466
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.614 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-14 0001564590-20-025466
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.017 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.025 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-14 0001564590-20-025466
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.025 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-14 0001564590-20-025466
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 1.172 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 1.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 15,660 2024-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 21,369 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 45.22 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 140 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 7,855 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079222
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 0.972 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079222
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 832 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 91,600 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-08 0001213900-17-011587
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 6.92 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 35 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 21,494 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price USD/shares 0.33 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001213900-17-008679
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 45 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 8.25 2017-06-09 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0.05 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0.05 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 35.65 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028326
us-gaap SharePrice Share Price USD/shares 6.29 2017-11-13 2017 FY 10-K 2018-03-12 0001193125-18-079222
us-gaap SharesPaidForTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation shares 359,316 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap ShortTermInvestments Short-term Investments USD 847,027 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 1,761 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 196,236 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-10 0001564590-21-012068
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 2.75M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.063 2016-12-20 2017 FY 10-K 2018-03-12 0001193125-18-079222
us-gaap StockIssued1 Stock Issued USD 2.15M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009827
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 1.18M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-10 0001564590-20-052980
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 50,637 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001213900-17-008679
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 46,500 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-08 0001213900-17-011587
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 794,097 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098531
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 12.95M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 5.47M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 30,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 13.48M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009827
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 2.92M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD -126,797 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 1.32M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 3 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009827
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 879,505 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 12.67M 2016-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079222
us-gaap TemporaryEquityDividendsAdjustment Temporary Equity, Dividends, Adjustment USD 287,779 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap TemporaryEquityForeignCurrencyTranslationAdjustments Temporary Equity, Foreign Currency Translation Adjustments USD -35,517 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 27 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 6,464 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-027998
us-gaap TreasuryStockShares Treasury Stock, Shares shares 808 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-027998
us-gaap TreasuryStockValue Treasury Stock, Value USD 6,464 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 644,600 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax USD -102,139 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-07 0000950170-25-065682
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 1,672 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap UnrealizedGainOnForeignCurrencyDerivativesBeforeTax Unrealized Gain on Foreign Currency Derivatives, before Tax USD 41,583 2022-04-01 2022-06-30 2022 Q2 10-Q 2022-08-03 0000950170-22-014267
us-gaap UnrealizedLossOnForeignCurrencyDerivativesBeforeTax Unrealized Loss on Foreign Currency Derivatives, before Tax USD 12,690 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-10 0001564590-21-012068
us-gaap UtilitiesOperatingExpense Utilities Operating Expense USD 2.00M 2023-01-31 2023 Q2 10-Q 2023-08-09 0000950170-23-040625
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -2.54M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0000950170-25-036349
us-gaap WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount USD -640,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-11 0001564590-22-019527
us-gaap WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1 USD 640,000 2021-10-01 2021-12-31 2022 FY 10-K 2023-03-13 0000950170-23-007560
us-gaap WarrantExercisePriceDecrease Warrant, Exercise Price, Decrease USD/shares 1.4 2017-12-04 2018 FY 10-K 2019-03-12 0001564590-19-007350
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 42.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 6.89M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-11 0001564590-22-019527
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 42.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453623

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →